Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 16, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	430	388	465	157	29	35
Market Cap Growth	-45.05%	-16.54%	195.83%	434.24%	-16.81%	-42.59%
Enterprise Value	406	373	468	159	27	31
Last Close Price	0.40	0.36	0.43	0.15	0.03	0.03
PE Ratio	13.30	8.64	-	7.81	8.26	3.97
PS Ratio	2.89	2.61	5.53	2.77	0.86	1.10
PB Ratio	4.35	3.92	8.68	2.73	1.01	1.40
P/TBV Ratio	4.35	3.92	8.73	2.74	1.03	1.43
P/FCF Ratio	18.83	16.99	79.70	-	-	5.88
P/OCF Ratio	18.10	16.33	62.33	-	8.81	5.43
EV/Sales Ratio	2.73	2.50	5.56	2.81	0.80	0.96
EV/EBITDA Ratio	7.78	7.24	20.43	13.09	5.25	4.94
EV/EBIT Ratio	8.12	7.46	22.05	14.75	6.92	6.11
EV/FCF Ratio	17.78	16.33	80.19	-	-	5.15
Debt / Equity Ratio	0.06	0.06	0.20	0.20	0.13	0.11
Debt / EBITDA Ratio	0.11	0.11	0.46	0.95	0.73	0.43
Debt / FCF Ratio	0.26	0.26	1.87	-	-	0.46
Net Debt / Equity Ratio	-0.24	-0.24	-0.01	0.08	-0.14	-0.23
Net Debt / EBITDA Ratio	-0.47	-0.47	-0.02	0.38	-0.75	-0.92
Net Debt / FCF Ratio	-1.05	-1.05	-0.07	-1.14	1.65	-0.96
Asset Turnover	1.27	1.27	0.93	0.91	0.90	1.05
Inventory Turnover	3.94	3.94	3.01	2.69	2.16	2.97
Quick Ratio	5.15	5.15	3.42	2.04	1.40	1.73
Current Ratio	6.45	6.45	4.88	3.07	2.75	2.82
Return on Equity (ROE)	58.89%	58.89%	-7.77%	46.47%	13.15%	43.01%
Return on Assets (ROA)	26.61%	26.61%	14.72%	10.83%	6.52%	10.33%
Return on Invested Capital (ROIC)	56.30%	61.65%	36.77%	24.74%	15.95%	29.14%
Return on Capital Employed (ROCE)	41.30%	41.30%	25.10%	15.30%	12.00%	17.80%
Earnings Yield	10.44%	11.57%	-0.93%	12.80%	12.11%	25.18%
FCF Yield	5.31%	5.88%	1.26%	-2.57%	-8.15%	17.00%
Buyback Yield / Dilution	-6.56%	-6.56%	-4.40%	-1.02%	-0.23%	-7.17%